Thursday, June 6
Friday, June 7
Saturday, June 8
Sunday, June 9
Session II: Strategic Regeneration: Biomaterial Selection and Surgical Techniques
Tissue Engineering: Can We Apply It Clinically?
Isabella RocchiettaThursday, June 6
10:45 am - 11:45 am
Grand Ballroom (Salon G-K)
Successful osseointegration is predicated on the placement of dental implants into a sufficient volume of bone. When teeth are lost due to trauma or periodontal disease, there is often a lack of adequate bone volume. A number of different techniques have been developed to reconstruct deficient alveolar ridges to allow dental implant placement in either a simultaneous or staged approach. Advances in tissue engineering may offer solutions that resolve bone volume deficits and soft tissue defects while at the same time eliminating some of the concerns posed by current techniques (eg, patient morbidity and predictability of results). Recombinant human platelet-derived growth factor (rh-PDGF-BB) has been extensively used as a potent regenerating factor in orthopedics and periodontics with success. The principal aim in hard tissue regeneration is to eliminate the need for autogenous bone harvesting and possibly eliminate the nonresorbable membrane. We are moving toward an era where less invasive treatment regimes are available to minimize complications and side effects of surgical procedures, increase success rates, and decrease patient morbidity and technical difficulties. The maturation of tissue engineering and its application to clinical surgical procedures has helped create a new paradigm.